Using a kind of novel linker technology, the startup is developing versions of incretin and non-incretin therapies that can ...
Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that its Board of Directors has appointed Mario Alberto Accardi PhD, President and founder of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback